Asymmetric Dimethylarginine as a Surrogate Marker of Endothelial Dysfunction and Cardiovascular Risk in Patients with Systemic Rheumatic Diseases

Asymmetric Dimethylarginine as a Surrogate Marker of Endothelial Dysfunction and Cardiovascular Risk in Patients with Systemic Rheumatic Diseases

The last few decades have witnessed an increased life expectancy of patients suffering with systemic rheumatic diseases, mainly due to improved management, advanced therapies and preventative measures. However, autoimmune disorders are associated with significantly enhanced cardiovascular morbidity...

Full description

Bibliographic Details
Main Authors: George D. Kitas, Theodoros Dimitroulas, Aamer Sandoo
Format: Article
Language:English
Published: MDPI AG 2012-09-01
Series:International Journal of Molecular Sciences
Subjects:
ADMA
rheumatic diseases
rheumatoid arthritis
atherosclerosis
cardiovascular disease
Online Access:http://www.mdpi.com/1422-0067/13/10/12315

Similar Items

Similar Items